Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
AMED Amedisys Inc
- Stocks
- Healthcare
- NASDAQ: AMED
Price (delayed)
$94.47
Market cap
$3.1B
P/E Ratio
34.35
Dividend/share
N/A
EPS
$2.75
Enterprise value
$3.27B
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients,
Highlights
AMED's EPS has soared by 108% from the previous quarter
The net income has soared by 108% QoQ
The gross margin has decreased by 2.3% YoY
Key stats
What are the main financial stats of AMED
Market
Valuations
Earnings
Shares outstanding
32.82M
Market cap
$3.1B
Enterprise value
$3.27B
Price to earnings (P/E)
34.35
Price to book (P/B)
3.02
Price to sales (P/S)
1.31
EV/EBIT
17.79
EV/EBITDA
13.34
EV/Sales
1.38
Revenue
$2.37B
Gross profit
$1.03B
Operating income
$106.28M
Net income
$89.84M
EBIT
$183.72M
EBITDA
$244.9M
Free cash flow
$219.44M
Per share
Balance sheet
Liquidity
EPS
$2.75
EPS diluted
$2.71
Free cash flow per share
$6.69
Book value per share
$31.27
Revenue per share
$72.32
TBVPS
$27.15
Total assets
$2.18B
Total liabilities
$939.5M
Debt
$452.01M
Equity
$1.2B
Working capital
$141.93M
Debt to equity
0.38
Current ratio
1.29
Quick ratio
1.23
Net debt/EBITDA
0.68
Margins
Efficiency
Dividend
EBITDA margin
10.3%
Gross margin
43.4%
Net margin
3.8%
Operating margin
4.5%
Return on assets
4.2%
Return on equity
7.8%
Return on invested capital
33.5%
Return on capital employed
10.9%
Return on sales
7.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AMED stock price
How has the Amedisys stock price performed over time
Intraday
-0.03%
1 week
-1.74%
1 month
3.31%
1 year
-1.3%
YTD
4.05%
QTD
1.99%
Financial performance
How have Amedisys's revenue and profit performed over time
Revenue
$2.37B
Gross profit
$1.03B
Operating income
$106.28M
Net income
$89.84M
Gross margin
43.4%
Net margin
3.8%
The company's net margin has surged by 111% QoQ
The net income has soared by 108% QoQ
The company's operating margin fell by 31% YoY but it rose by 13% QoQ
AMED's operating income is down by 27% year-on-year but it is up by 12% since the previous quarter
Price vs fundamentals
How does AMED's price correlate with its fundamentals
Growth
What is Amedisys's growth rate over time
Valuation
What is Amedisys stock price valuation
P/E
34.35
P/B
3.02
P/S
1.31
EV/EBIT
17.79
EV/EBITDA
13.34
EV/Sales
1.38
AMED's EPS has soared by 108% from the previous quarter
The P/E is 75% below the 5-year quarterly average of 139.9 and 21% below the last 4 quarters average of 43.3
The P/B is 41% less than the 5-year quarterly average of 5.1 but 8% more than the last 4 quarters average of 2.8
AMED's equity is up by 10% year-on-year and by 6% since the previous quarter
The P/S is 38% less than the 5-year quarterly average of 2.1
Amedisys's revenue has increased by 5% YoY
Efficiency
How efficient is Amedisys business performance
AMED's ROS has soared by 166% YoY and by 48% from the previous quarter
The ROA has soared by 110% since the previous quarter
The ROE has soared by 105% from the previous quarter
The ROIC has soared by 54% from the previous quarter
Dividends
What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AMED.
Financial health
How did Amedisys financials performed over time
AMED's total assets is 133% higher than its total liabilities
The quick ratio has increased by 24% YoY and by 5% QoQ
The current ratio has increased by 18% YoY and by 4.9% QoQ
The company's debt is 62% lower than its equity
The debt to equity has contracted by 14% YoY and by 5% from the previous quarter
AMED's equity is up by 10% year-on-year and by 6% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.